Latest Content

Linda’s Treatment History and Challenges in Coping With Multiple Relapses

March 24th 2025, 8:05pm

By Saad Usmani, MD

Video

Panelists discuss how multiple myeloma patients often navigate through numerous treatment regimens over their disease course, frequently cycling through five to 10 different therapeutic approaches since diagnosis, with the greatest challenges being management of cumulative side effects, emotional fatigue from repeated relapses and maintaining hope while facing increasingly limited options as they progress to late-line therapy.

Challenges in Managing Late-Line RRMM

March 24th 2025, 8:03pm

By Saad Usmani, MD

Video

Panelists discuss how the term “late-line” emerged organically in clinical practice to describe patients who had exhausted multiple treatment options, with most experts recalling its growing usage over the past decade as novel therapies expanded the treatment landscape and created a need to distinguish between patients with early and more heavily pretreated relapsed/refractory multiple myeloma (R/R MM).

Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer

March 24th 2025, 8:00pm

By Dr. Sheri Prentiss

Video

Dr. Sheri Prentiss discusses what steps patients can take to ensure they're being screened for lymphedema prior to starting their breast cancer treatment.

First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer

March 24th 2025, 7:00pm

By Spencer Feldman

Article

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

How Hope Erased My Fear of Testicular Cancer

March 24th 2025, 5:09pm

By Brian Sluga

Article

Hope helped me navigate my testicular cancer diagnosis at 20, shaping my resilience and guiding my journey as a survivor.

Cretostimogene Has Durable Response in BCG-Unresponsive Bladder Cancer

March 24th 2025, 4:00pm

By Ryan Scott

Article

Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ

Phase 3 Study Design Finalized with FDA for IMNN-001 in Ovarian Cancer

March 24th 2025, 3:00pm

By Alex Biese

Article

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory agencies.

Colorectal Cancer Awareness: Key Signs, Screening and Prevention

March 24th 2025, 1:00pm

By Spencer Feldman

Article

Dr. Zachariah H. Foda discusses key colorectal cancer warning signs, the rise in younger diagnoses and more.

Unraveling Disparities and Genomic Advances Across Breast Cancer Care

March 23rd 2025, 6:00pm

By Ryan Scott

Article

Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.

Reducing Bowel Complications Following Radiation in Prostate Cancer

March 23rd 2025, 2:00pm

By Ryan Scott

Article

SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation therapy in prostate cancer.

First Patients Dosed in WU-CART-007 Trial for Blood Cancer Subtypes

March 22nd 2025, 6:00pm

By Alex Biese

Article

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma.

Padcev With or Without Keytruda Elicits Responses in Urothelial Cancer

March 22nd 2025, 2:00pm

By Alex Biese

Article

In metastatic urothelial carcinoma, Padcev plus Keytruda elicited responses in the first-line setting, with Padcev showing benefit in later lines.

First Patent Dosed With Pocenbrodib in Trial for Metastatic Prostate Cancer

March 21st 2025, 9:00pm

By Spencer Feldman

Article

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

Advancing ctDNA for Minimal Residual Disease Detection in Breast Cancer

March 21st 2025, 8:00pm

By Ryan Scott

Article

Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.

Emphasizing the Importance of Breast Cancer Education and Screenings

March 21st 2025, 7:00pm

By Patricia Jakel, RN

Video

Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.